Echo Therapeutics Waiting to Hear Back from FDA
On November 11th of this year, Echo Therapeutics Inc™, a transdermal medical device company based out of Franklin, Massachussetts, submitted their revolutionary Prelude SkinPrep System™ […]
382
OneMedForum New York 2010 Successfully Brings Together Innovators and Investors
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Making Diabetes Less Painful to Deal With
Diabetes patients don’t always engage in the self-care needed to control the disease.
Echo Therapeutics Rated Strong Spec Buy by Life Tech Capital
The significant differences between Echo Therapeutics’ Symphony system and the competition is the needle-free transdermal biosensor, clinical trials in the hospital setting and biosensor life.
Echo Therapeutics: Positive Developments for Needle-Free Monitoring System
On 11/19/09, the Company announced positive results in a pilot clinical study which included Prelude skin preparation and the placement of 10 Symphony tCGM biosensors on subjects with Type 1 or Type 2 Diabetes.